Veryan Medical Ltd.
- Home
- Companies
- Veryan Medical Ltd.
- Articles
- MIMICS-2 at 1 year: 3D stent meets ...
MIMICS-2 at 1 year: 3D stent meets safety & effectiveness goals
Feb. 11, 2018- By: Caitlin E.Cox
Courtesy ofVeryan Medical Ltd.
The TCTMD reports on Timothy Sullivan`s presentation at the International Symposium on Endovascular Therapy. In terms of 12-month primary patency, the strategy of "natural swirling flow is an alternative to antiproliferative drugs," the researcher says.
Most popular related searches